Description :
Tenders for Supply Of Essential 12 Drugs - 3fdc(p) (h50, R75, Z150) [dstb-ip(p)(isoniazid Ip 50 Mg(h) + Rifampicin Ip 75 Mg(r) + Tab Pyrazinamide Ip 150mg(z))each Fdc Tablet Contains:- Isoniazid Ip 50 Mg(h) + Rifampicin Ip 75 Mg(r) + Tab Pyrazinamide Ip 150mg(z) & Specification As Per Annexure-a Of The Referred Tender No. E-630176/12371, Dated 18.03.2025., 2fdc (p) (h50 & R75) [dstb-cp(p)each Fdc Tablet Contains:-isoniazid Ip 50 Mg (h) + Rifampicin Ip 75 Mg (r ) & Specification As Per Annexure-b, Of The Referred Tender No. E-630176/12371, Dated 18.03.2025., Cycloserine Each Capsule Contain:-cycloserine 250 Mg & Specification As Per Annexure-d, Of The Referred Tender No. E-630176/12371, Dated 18.03.2025., Ethambutol Each Tablet Contain:-ethambutol Hydrochloride 100 Mg & Specification As Per Annexure-e, Of The Referred Tender No. E-630176/12371, Dated 18.03.2025., Ethambutol Each Tablet Contain:-ethambutol Hydrochloride 400mg & Specification As Per Annexure-f, Of The Referred Tenderno. E-630176/12371, Dated 18.03.2025., Ethambutol Each Tablet Contain:-ethambutol Hydrochloride 800mg & Specification As Per Annexure-g, Of The Referred Tenderno. E-630176/12371, Dated 18.03.2025., Isoniazid Each Tablet Contain:-isoniazid 300mg & Specification As Per Annexure-h,of The Referred Tenderno. E-630176/12371, Dated 18.03.2025., Levofloxacin Each Tablet Contain:-levofloxacin 250 Mg & Specification As Per Annexure-i, Of The Referred Tenderno. E-630176/12371, Dated 18.03.2025., Pyrazinamide Each Tablet Contain:-pyrazinamide 500mg & Specification As Per Annexure-j, Of The Referred Tenderno. E-630176/12371, Dated 18.03.2025., Pyrazinamide Each Tablet Contain:-pyrazinamide 750mg & Specification As Per Annexure-k, Of The Referred Tenderno. E-630176/12371, Dated 18.03.2025., Pyridoxine Each Tablet Contain:-pyridoxine Hydrochloride 100 Mg & Specification As Per Annexure-l, Of The Referred Tenderno. E-630176/12371, Dated 18.03.2025., Rifampicin Each Tablet/ Capsule Contain:-rifampicin 300mg & Specification As Per Annexure-n, Of The Referred Tenderno. E-630176/12371, Dated 18.03.2025.
